Literature DB >> 10861495

Down-regulation of p27 is a significant predictor of poor overall survival and may facilitate metastasis in colorectal carcinomas.

J Yao1, K W Eu, F Seow-Choen, P Y Cheah.   

Abstract

The p27 gene product has been shown to have prognostic significance in a range of tumors. Down-regulation of p27 has also been implicated in loss of cell adhesion in tumor cells. Our study aimed to investigate whether p27 expression was significantly correlated with overall survival of colorectal carcinoma patients in the Singapore population, which is predominantly Chinese. Staining was performed on 136 paraffin-embedded specimens collected between 1991 and 1992 using an anti-p27 monoclonal antibody. Follow-up of patients was until time of death or for 5 years. There was a significant association between overall survival and p27 expression for all specimens. However, there was no significant correlation between p27 expression and other clinical features such as gender, age, tumor stage, differentiation, and site. When stratified by tumor stage, patients whose tumors exhibited higher metastatic potential (stage III/IV) but had strong p27 expression had a median survival that was 23 months longer than stage III/IV patients whose tumors had no or weak p27 expression. Our results thus suggest that one potential mechanism of action of p27 is to suppress metastasis possibly through its involvement in cell adhesion. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10861495

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  SMAD4 protein expression and cell proliferation in colorectal adenocarcinomas.

Authors:  Adriana Handra-Luca; Sylviane Olschwang; Jean-François Fléjou
Journal:  Virchows Arch       Date:  2011-10-16       Impact factor: 4.064

2.  p27kip1 in intestinal tumorigenesis and chemoprevention in the mouse.

Authors:  Wancai Yang; Laura Bancroft; Jiao Liang; Min Zhuang; Leonard H Augenlicht
Journal:  Cancer Res       Date:  2005-10-15       Impact factor: 12.701

Review 3.  [Clinical, pathological and molecular prognostic factors in colorectal carcinomas].

Authors:  S E Baldus
Journal:  Pathologe       Date:  2003-01-21       Impact factor: 1.011

4.  Can the clinical outcome in stage II colon carcinomas be predicted by determination of molecular marker expression?

Authors:  J M Fernández-Cebrián; M Nevado Santos; P Vorwald Kuborn; M Pardo de Lama; J Martín-Cavanna; P Pacheco Martínez; B Fernández Escudero; M Ramos Fernández
Journal:  Clin Transl Oncol       Date:  2007-10       Impact factor: 3.405

5.  Genetic deficiency of decorin causes intestinal tumor formation through disruption of intestinal cell maturation.

Authors:  Xiuli Bi; Chang Tong; Ashley Dockendorff; Laura Bancroft; Lindsay Gallagher; Grace Guzman; Renato V Iozzo; Leonard H Augenlicht; Wancai Yang
Journal:  Carcinogenesis       Date:  2008-06-12       Impact factor: 4.944

6.  Selenium and sulindac are synergistic to inhibit intestinal tumorigenesis in Apc/p21 mice.

Authors:  Xiuli Bi; Nicole Pohl; Huali Dong; Wancai Yang
Journal:  J Hematol Oncol       Date:  2013-01-17       Impact factor: 17.388

7.  Expression of p27Kip1 and E-cadherin in Head and Neck Squamous Cell Carcinoma of Indonesian Patients.

Authors:  Auerkari E I; Joewono V; Handjari D R; Sarwono A T; Suhartono A W; Eto K; Ikeda M A
Journal:  Open Dent J       Date:  2014-09-08

8.  TLE4 promotes colorectal cancer progression through activation of JNK/c-Jun signaling pathway.

Authors:  Shu-Yang Wang; Ke Gao; Dan-Ling Deng; Juan-Juan Cai; Zhi-Yuan Xiao; Liu-Qing He; Hong-Li Jiao; Ya-Ping Ye; Run-Wei Yang; Ting-Ting Li; Li Liang; Wen-Ting Liao; Yan-Qing Ding
Journal:  Oncotarget       Date:  2016-01-19

9.  Clinical significances of p27 in digestive tract cancers: a comprehensive analysis on immunohistochemistry staining, published literatures, microarray and RNA-seq data.

Authors:  Dan-Dan Xiong; Rong-Quan He; Ai-Hua Lan; Wen-Jie Chen; Yi-Huan Luo; Zhi-Hua Ye; Jie Ma; Gang Chen; Yi-Wu Dang
Journal:  Oncotarget       Date:  2018-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.